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Over the last fifteen years, our understanding of the pathophysiology of atrial fibrillation (AF) has paved the way for ablation to
be utilized as an eﬀective treatment option. With the aim of gaining more detailed anatomical representation, advances have been
made using various imaging modalities, both before and during the ablation procedure, in planning and execution. Options have
flourished from procedural fluoroscopy, electroanatomic mapping systems, preprocedural computed tomography (CT), magnetic
resonance imaging (MRI), ultrasound, and combinations of these technologies. Exciting work is underway in an eﬀort to allow
the electrophysiologist to assess scar formation in real time. One advantage would be to lessen the learning curve for what are very
complex procedures. The hope of these developments is to improve the likelihood of a successful ablation procedure and to allow
more patients access to this treatment.
1. Introduction
Atrial fibrillation (AF) is the commonest cardiac arrhythmia
and carries with it significant morbidity and mortality,
specifically increasing risk of stroke and heart failure.
With increasing age, AF becomes a more prevalent
problem, from 0.5% at 50–59 years to almost 9% at age 80–
89 years from US registry data [1]. Figures as high as 17%
in those aged 84 years and above have been quoted from
European populations [2]. The associated economic burden
is considerable and accounts for approximately 1% of the
UK’s National Health Service (NHS) budget currently, which
is expected to rise two-fold in the next 25 years [3].
Management of AF requires individual tailoring to each
patient, considering rhythm versus rate control strategies,
and managing embolic risk. Since the introduction of the
new European Society of Cardiology guidelines on the
management of AF, the potential application of catheter
ablation has expanded. Catheter ablation is recommended
for those patients who are symptomatic and have failed at
least one antiarrhythmic medication [4].
However, considering patients with minimal or no heart
disease, who are symptomatic with paroxysmal AF, the
relative safety of the technique in the hands of experienced
operators make it suitable for catheter ablation to be
considered as an initial therapy in this selected population.
Moreover, given the frequent and serious adverse eﬀects
associated with long-term amiodarone treatment, in younger
patients it is reasonable to consider catheter ablation as an
alternative.
Given the complexity and invasive nature of AF ablation,
with the small risk of severe complications, there must
be suﬃcient potential benefit to justify the procedure
for each individual. Patients with either persistent AF or
long-standing persistent AF tend to require extensive and
repeated ablation procedures. In addition, in patients with
structural heart disease (congestive heart failure, coronary
artery disease, and left ventricular hypertrophy) success with
catheter ablation is more diﬃcult to achieve. Therefore in
these groups, given the lack of a clear benefit-risk ratio,
it seems reasonable to recommend that they should be
refractory to antiarrhythmic medication before ablation is
considered [4].
Interestingly, there is evidence that patients with AF-
related comorbidity may gain from a primary ablation
strategy. In those with heart failure, left atrial ablation
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conferred significant improvements in ejection fraction and
functional end-points such as exercise tolerance [5, 6].
The atrial contribution to the ejection fraction achieved by
restoring sinus rhythm in this setting is around 10% [7].
2. Ablation Strategies
The initial strategy of catheter ablation for atrial fibrillation
spawned from the success of the surgical maze procedure,
where the atria are cut into electrically disconnected pieces
that are too small to sustain AF [8, 9]. From 1995 to 1997,
the most common technique employed was the right atrial
maze ablation, which enjoyed limited success [9, 10].
Since the demonstration, in 1998, that the majority of
patients with paroxysmal AF have the arrhythmia originating
from pulmonary vein ectopy [11], catheter ablation has
become a far more successful and common intervention. In
the US, approximately 50,000 ablations are performed per
year, with 60,000 AF ablations in Europe per year.
Unfortunately, at present, there exists a substantial unmet
demand for catheter ablation due to the lack of centres with
operators able to perform the procedure. Catheter ablation is
technically demanding and operators require a high degree of
skill and experience, integrated with an intimate knowledge
of anatomy and electrophysiology of the left atrium. This
leads to long training times for an electrophysiologist to
become fully trained in AF ablation. Even in the hands of the
most proficient, success rates for a single ablation procedure
for paroxysmal AF are only in the magnitude of 60–85%
[12, 13]. For persistent AF, pulmonary vein isolation alone
is able to maintain sinus rhythm in only 10–30% of patients
[14–16].
There are a few possibilities to account for procedure
failure. The first is that the pulmonary vein was not truly
isolated at the index procedure. The second is that the
ablated tissue recovers conduction and the third relies on the
development of a new connection. The most likely cause for
pulmonary vein reconduction is the first, inadequate lesion
delivery at the original procedure. Factors contributing to
this include poor catheter stability, inability to achieve
transmural lesions, and acute tissue oedema which can
cause both temporary isolation and limits power delivery to
underlying tissue [17].
In the case of persistent AF, the lower success rates may
be attributed to the atria being, more commonly, larger and
having more fibrosis [18]. The electrical remodelling that
occurs with persistent AF changes the substrate for arrhyth-
mia, so that success with a curative ablation approach, in
comparison to paroxysmal AF, is more likely to depend on
targeting additional triggers within atrial substrates outside
the pulmonary veins [19–21]. As such, often more than one
ablation procedure is required to achieve electrical isolation,
including the delivery of left atrial linear lesions [22]. Two
such useful lines are the left atrial roof line and the lateral
mitral isthmus line [23, 24].
Adding complexity to the achievement of successful
pulmonary vein isolation is the variable anatomy of the pul-
monary veins. Normally, the left atrium has four pulmonary
veins draining into it, right and left superior and inferior
veins; however, anatomical variants exist. Commonly, these
include an additional right middle vein (present in 23% of
cases), common ostia (e.g., a left common ostia is seen in
35% of cases) and, less commonly, pulmonary veins that
connect to the left atrium by its roof. Successful outcome
is determined by the ability to completely electrically isolate
these veins [25–27].
Technology has a role here to tackle these factors and
improve the success of ablation procedures. Specifically,
advances in imaging allow better anatomical localization of
left atrial structures to guide lesion delivery and prevent
complications. These, although rare, can be devastating.
When procedures are performed in high-volume centres
by high-volume operators, outcomes are better, and major
complication rates have been reported in the order of 2-3%
[7, 28–33]. However, on a worldwide scale, major compli-
cations may be as high as 6% [34]. These may range from
complications relating to any vascular access procedure to
transient ischaemic attack, stroke, pulmonary vein stenosis,
atrio-oesophageal fistula formation, valve damage, cardiac
tamponade, and death [4].
3. Imaging to Help the Electrophysiologist
At present, no imaging modality can serve as a substitute
to operator experience and appreciation of each patient’s
individual anatomy. There is no definitive evidence that any
imaging tool used in addition to simple fluoroscopy leads to
improved patient outcomes. However, the learning curve to
AF ablation is substantial, and advanced imaging modalities
may accelerate this process, provide a safety aspect to less
experienced operators, and make ablation procedures easier
and quicker.
Every clinical electrophysiology (EP) laboratory is
equipped with an X-ray system designed to provide flu-
oroscopic imaging of the heart. For many years this was
the only form of procedural imaging available, occasionally
being supplemented with transoesophageal and transtho-
racic echocardiography in limited cases. Common to all X-
ray imaging, although cardiac catheters are well visualised,
the soft tissue of myocardium is not. Imaging of the
cardiac chambers is indirect through relation to the cardiac
silhouette (Figure 1). Even with the limited information
gained, selective pulmonary venous angiography is able to
help to delineate the pulmonary venous antrum and guide
ablation. The walls of the left atrium can be indirectly
assessed by bolus injection of contrast, which can be
augmented by manoeuvres that minimize atrial emptying
such as adenosine or rapid ventricular pacing. Critically,
during ablation procedures, fluoroscopy can be used to
detect complications from the procedure, such as cardiac
tamponade where the excursion of the cardiac silhouette
decreases before the development of any clinical compromise
in the patient [35]. Inadvertent pericardial puncture and
aortic puncture can be identified with characteristic flows
of contrast. However, the major disadvantage of using X-
ray fluoroscopy as the sole imaging modality is that all
images obtained are two-dimensional representations of
three-dimensional structures.
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Figure 1: Fluoroscopy as a sole imaging modality. Fluroscopy is still one of the most widely used imaging modalities to guide ablation.
Considerable experience is needed to interpret the images and perform a safe procedure. (a) Demonstrates staining of the interatrial septum
prior to transeptal puncture (b), at which point a small amount of contrast can just be seen in the left atrium after being injected via the
transseptal needle. In (c) a large loop has been made by the ablation catheter, which opposes to the walls of the left atrium. In (d) the ablation
catheter is at the ostium of the left superior pulmonary vein with the circular mapping catheter in the left superior vein. The diﬃculty that
fluoroscopy has in visualising soft tissue is apparent.
4. Electroanatomic Imaging Modalities
To combat some of these problems, electroanatomic map-
ping systems were developed. These systems used mag-
netic fields or changes in impedance to generate a three-
dimensional geometric map of the left atrium. In this way
the ablation catheter is localised in three-dimensional space.
As with most imaging technologies in their infancy, the maps
generated were fairly crude representations of the complex
left atrial anatomy (Figure 2).
Further developments of the imaging systems have
led to more accurate representations of the left atrium.
The first that came into use for the planning of ablation
procedures was preprocedural computed tomography (CT).
Although the images obtained of the left atrium were
of great value to the operator, unfortunately, CT images
could not be displayed concurrently with the fluoroscopic
imaging acquired in the electrophysiology lab during the
procedure initially. Sophisticated software was used to bridge
the gap by development of systems capable of overlaying the
segmented CT images of the left atrium directly onto the
live fluoroscopy screen [36] or into a 3D electroanatomic
mapping system [37–42]. For the electrophysiologist, this
brought the beginning of 3D representation of individual
patient’s cardiac anatomy into the procedural lab, displayed
over real-time fluoroscopy. A secondary benefit was that
extracardiac structures could also be visualized, such as the
oesophagus. When ablating in the posterior wall of the left
atrium, one of the most feared and lethal complications
that can occur is the formation of an oesophageal fistula
[43–45]. By displaying the relationship of the oesophagus
to the left atrium, adjustments can be made to the energy
delivered through ablation lesions, aiming to minimize this
risk.
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Figure 2: 3D electroanatomic imaging. The CARTO system uses small magnets in the tip of the catheter that are able to accurately locate the
tip of the catheter within a small magnetic field created by magnets placed under the patient. Using this system, the catheter is moved within
the patient’s heart to build a 3D shell. Activation timing can be allocated to each point that has been collected to form activation maps. The
3D representation of the left atrium with this early system is still someway from a true representation. (a, b) Demonstrate a posteroanterior
and anteroposterior views of a reconstructed left atrium. Ablation lesions have been added during ablation in (c). (d) Is an activation map
of the left atrium in a patient with perimitral flutter. The diﬀerent colours represent isochrones of activation. The entire cycle length can be
seen around the mitral annulus.
This integrated system requires manual registration of
the segmented left atrium to the patient with various
methods available to achieve this. Despite this adjustment,
images are remarkably accurate to within 0.3mm [46].
However, registration of the 3D images is sometimes diﬃcult
due to changes that have occurred between the CT scan
taking place and the ablation procedure. This underlies one
of the most important limitations of this imaging modality.
The usual lag time between CT scan and ablation procedure
is a matter of days. During this time the patient’s rhythmmay
have changed, the volume status of the patient is likely to be
diﬀerent, and, most importantly, the patient’s position on the
procedure table is diﬀerent to that in the CT scanner. These
changes may aﬀect the left atrium; however, it is not known
whether they produce clinically relevant diﬀerences.
Superseding CT imaging, with the aim of overcoming
these diﬃculties, rotational angiography was developed [25,
26, 47–50]. Onemajor advantage is that this modality utilizes
the fluoroscopy system that is routinely available in the
electrophysiology lab. With rotational angiography, the left
atrium is isocentred and opacified with contrast, which can
be achieved in a variety of ways [25, 47, 51], then the C-arm
rotates around the patient in a 240◦ arc over 4 seconds. The
data set created is read by the electrophysiology system in the
same way as a preprocedural CT scan. As such, imaging is
performed during the procedure and displayed on the live
fluoroscopy screen (Figure 3).
Registration accuracy is not a concern; this can be
checked rapidly by placing a catheter within the superior
pulmonary veins and looking for the drop oﬀ between
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Figure 3: Rotational angiography. A tremendous improvement on fluoroscopy was the development of rotational angiography. Here the
C-arm used for fluoroscopy rapidly rotates around the patient while contrast opacifies the left atrium. ((a) Contrast injected in the right
atrium and then a delay of 8 seconds until the LA opacifies, (b) direct injection into the left atrium), following segmentation of the resulting
dataset, which is semiautomatic; a 3D anatomical accurate shell can then be superimposed on the live fluoroscopy (c) to aid with ablation,
or exported to other mapping systems.
the pulmonary vein ostium and the left atrial body. If the
patient moves during the procedure, the anatomy can be
re-registered quickly, using the trachea as an anatomical
landmark [52]. Another advantage of rotational angiography
over CT is that the radiation dose to the patient is less.
The operator is able to see the exact position of critical
structures including the ostia of the pulmonary veins, any
anomalous pulmonary veins, and the ridge between the
left atrial appendage and the left superior vein. This has
the potential to improve the success of pulmonary vein
isolation through accurate anatomical planning and also
avoid pulmonary vein stenosis, which occurs in around 1–
3% of cases [53], when ablation is performed inside the
pulmonary vein.
These imaging tools have yet to translate into clear
improvement in patient outcomes [54, 55]. In one retrospec-
tive study, there was a suggestion that 3D electroanatomical
systems with integrated CT imaging led to better proce-
dural outcomes [37]. The same group later published a
prospective randomised trial, which did not demonstrate
any diﬀerence in patient outcomes when CT integration
was employed [41]. As the authors concluded, procedural
success is dependent on the successful isolation of pulmonary
veins, regardless of the technology used to achieve it. This
has further been backed up by data on patients undergoing
lung transplantation. In patients receiving double lung
transplantation (which results in “isolation” of all pulmonary
veins) virtually no patients (0.5%) went on to have AF
compared to 30% of similar patients undergoing either single
lung transplantation or thoracic surgery [56].
Comparing Carto XP to rotational angiography, a two-
centre study, with over 90 patients, demonstrated equivalent
results in procedural success and fluoroscopy times. A further
study by the same group did not demonstrate any diﬀerences
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Figure 4: Left atrial magnetic resonance imaging. Postprocedural imaging of the left atrium with delayed enhancement ((a, b)) and T2
weighted (c) to assess left atrial scar and oedema, respectively. The raw image is processed to obtain a 3D representation of the anatomy, with
colour-coded representation, which is thought to represent scar formation and oedema. The images may help guide ablation (d). Images
courtesy of Ben Knowles and Kawal Rhode, Kings College London and St. Thomas’ Hospital.
in procedural or clinical outcome when comparing patients
who had the procedure using rotational angiography or a 3D
electroanatomic imaging system [52].
5. Lesion Formation
Despite these tremendous advances in imaging, there is
one important area that has not seen comparable growth.
This is in the assessment of tissue contact, which is a key
determinant of successful lesion development [57].
Currently, systems are being developed to assess and
control tissue contact, including robotic [58–61] or magnetic
catheter navigations [62–64] and sensors in the catheter tip
detecting force [65, 66].
However, at present, forms of lesion assessment are
indirect, using changes in tissue impedance, diminution of
local electrogram voltage and assessment of contact force.
Magnetic Resonance (MR) imaging shows promise in its
ability to visualize scar formation in the left atrium [67–
72]. Currently in its infancy for studying the left atrium,
interesting reports have emerged in its use following ablation
procedures. In a case report, a gap identified in a linear
lesion seen on preproceduralMRwas found to be responsible
for an atrial tachycardia. Ablation at this gap, achieving
physiological block of the line, resulted in termination of the
arrhythmia [73].
Cardiac MRI has been used to investigate the correlation
between points of energy delivery and scar formation. One
study showed that 20% of sites where energy was thought
to have been delivered had no evidence of scar formation
[74]. Furthermore, another study demonstrated that oedema
formation might contribute to pulmonary vein isolation
acutely. Therefore, on resolution of oedema, the possibility
of pulmonary vein reconduction arises [72].
At present, the clinical information provided by MR on
lesion formation is only available following the procedure
(Figure 4). In the future, MR imaging may allow real-time
imaging of the catheter; however, real-time lesion assessment
has not yet been developed [75]. Real-time assessment of
the ablation lesion is currently regarded as a holy grail in
electrophysiology. Recent work in a sheep model has demon-
strated that ultrasound, integrated into an ablation catheter,
was able to detect changes in tissue structure that correlate
with tissue necrosis [76]. This novel integrated ultrasound
catheter was tested in an in vivo sheep model, using both
atrial and ventricular lesions. Impressively, for lesions up to
5mm in depth, accurate real-time myocardial imaging could
be used to diﬀerentiate between tissue necrosis and viable
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Figure 5: Real-time respiratory-gated motion compensation. A
system is being developed whereby the 3D shell of the left atrium
(either from CT/MR or rotational angiography) moves during
the abaltion in response to respiratory motion. This example
demonstrates how the trachea is automatically tracked. Image
courtesy of Kawal Rhode, Kings College London and St. Thomas’
Hospital.
tissue. Although this shows promise, further work with this
technology is required in clinical trials.
6. Conclusions
Over recent years, technological advances in the field have
been astounding; the EP lab of the future has even more pos-
sibilities. Currently overlaid 3D images are static; however, in
the future, real-time visualisation of cardiac contraction and
diaphragmatic movement (Figure 5) holds the possibility of
more accurate catheter placement and avoiding inadvertent
ablation within the pulmonary veins. New information from
MR images relaying anatomical areas of fibrosis could be
projected onto the 3D lab images.
Advances in imaging provide much greater anatomical
detail of myocardium, which is only half of the story.
Electrophysiology is the integration of discrete anatomical
structures with discrete electrical properties. Work on soft-
ware prototypes is currently underway, which will allow
electrical data from the EP recording system to be displayed
in colour-coded format on the 3D overlay [77]. This could
allow for dominant frequency mapping and wavelet analysis
in AF in an eﬀort to localise areas critical to the AF process,
as well as demonstrating complete conduction block across
linear lesions with ease [77].
In summary, imaging tools in current use give the
electrophysiologist information that could be obtained by
using simple fluoroscopy and possessing considerable oper-
ator experience. The success of an AF ablation procedure
is crucially dependent on pulmonary vein isolation; it
is the accurate understanding of each patient’s anatomy
that ensures this. Detailed anatomical imaging aﬀords the
operator an insight into the complex anatomy of the left
atrium andmakes the goal more readily achievable, although
there is a lack of evidence translating this into improved
patient outcomes. Assessments of tissue contact and lesion
development remain outside the grasp of the practicing
electrophysiologist; however, this may change in years to
come. Ultimately, these technologies need to demonstrate
proven benefit to patients in procedural success and reducing
complications, when compared to current practice.
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